| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||||
Net income (loss) | ||||||||
-17,849 | -33,737 | -29,672 | -26,948 | -23,958 | -22,799 | 0 | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||||||||
Depreciation and amortization | ||||||||
2,888 | 2,700 | 2,474 | 2,082 | 1,887 | 1,700 | 0 | 0 | 0 |
Stock-based compensation | ||||||||
2,511 | 1,886 | 1,444 | 1,010 | 622 | 263 | 0 | 0 | 0 |
Changes in operating assets and liabilities: | ||||||||
Prepaid expenses and other assets | ||||||||
2,752 | 4,255 | 3,590 | 2,720 | 878 | 19 | 0 | 0 | 0 |
Accounts payable | ||||||||
-675 | -622 | 659 | 337 | 1,868 | 1,342 | 0 | 0 | 0 |
Accrued liabilities | ||||||||
2,213 | 2,460 | 1,708 | 1,372 | 380 | 847 | 0 | 0 | 0 |
Deferred rent | ||||||||
0 | - | - | - | 0 | - | - | - | - |
Deferred revenue | ||||||||
-25,868 | -4,347 | 0 | 0 | 0 | - | - | - | - |
Net cash used in operating activities | ||||||||
-39,137 | -35,623 | -3,161 | 67 | 5,715 | 7,992 | 0 | 0 | 0 |
Cash flows from investing activities: | ||||||||
Maturities of marketable securities | ||||||||
0 | - | - | - | - | - | - | - | - |
Purchase of marketable securities | ||||||||
0 | - | - | - | - | - | - | - | - |
Purchase of property and equipment | ||||||||
3,881 | 3,371 | 4,461 | 4,277 | 3,533 | 3,063 | 0 | 0 | 0 |
Net cash provided by (used in) investing activities | ||||||||
-297,615 | -303,923 | -178,666 | -4,277 | -3,533 | -3,063 | 0 | 0 | 0 |
Cash flows from financing activities: | ||||||||
Proceeds from issuances of common stock | ||||||||
152 | 119 | 0 | 0 | 0 | - | - | - | - |
Proceeds from the term loan | ||||||||
- | 4,540 | 0 | 0 | 0 | - | - | - | - |
Deferred financing costs | ||||||||
- | - | - | - | 0 | - | - | - | - |
Payments of the term loan | ||||||||
0 | - | - | - | 409 | 400 | 0 | 0 | 0 |
Net cash used in (provided by) financing activities | ||||||||
239,833 | 243,043 | 172,466 | 172,464 | 124,487 | 121,417 | 0 | 0 | 0 |
Net decrease in cash, cash equivalents and restricted cash | ||||||||
-96,919 | -96,503 | -9,361 | 168,254 | 126,669 | 126,346 | 0 | 0 | 0 |
Supplemental disclosures of cash flow information: | ||||||||
Cash paid for interest | ||||||||
203 | 191 | 144 | 93 | 41 | 25 | 0 | 0 | 0 |
Supplemental disclosures of noncash investing and financing activities: | ||||||||
Purchase of property and equipment included in accrued liabilities | ||||||||
154 | 73 | 0 | 0 | 0 | - | - | - | - |
Deferred financing costs included in accrued liabilities | ||||||||
- | 1 | 0 | 0 | 0 | - | - | - | - |